Reference Range:
Pediatric (less than 3 years)
CD 19 (B-cells): 11% - 45%
Adult
CD 19 (B-cells): 4% - 25%
Methodology:
Documentation
This test was developed and the performance characteristics determined by Parkview Health Laboratories. This test has not been cleared by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA-88) as qualified to perform high complexity clinical laboratory testing.